COVID-19 vaccines have been around for half a year, what have we learned so far?

(Credit: Unsplash)

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.

Author: John Letzing, Digital Editor, Strategic Intelligence, World Economic Forum


  • Signs are so far encouraging in terms protection, safety, and saving lives.
  • More than 2 billion doses have been administered globally.
  • However, many people may not receive a single dose for at least another year.

One thing we know for sure: they don’t make you magnetic.

Those fortunate enough to receive the first available doses of COVID-19 vaccines have been serving as test subjects. Roughly half a year into this global experiment, what have we learned so far?

A pair of studies published last month suggested that vaccination can indeed provide a plausible path out of the pandemic, and by early June 2 billion doses had been administered worldwide since the first went to a woman in the UK the previous December.

COVID-19 vaccines had saved nearly an estimated 12,000 lives in England alone by last month, China has been vaccinating a population the size of Romania every day, and San Francisco, where nearly 70% of residents had been fully vaccinated as of early this month, is the first US city on the verge of herd immunity.

Globally, daily confirmed cases and deaths have been trending downward since April. So far, it’s safe to say, vaccines seem to be working well.

One real-world study published in March of people in Denmark prioritized for the Pfizer-BioNTech vaccine found it was 90% effective among healthcare workers, and 64% effective among residents of long-term care facilities with a median age of 84.

However, troubling variants like “Delta” in India, the UK, and the US have raised questions about their potential resilience to vaccines. A study published in the UK last month found that two doses of the Pfizer-BioNTech vaccine were 88% effective against symptomatic disease from Delta, though epidemiologists have warned that variants could ultimately render current vaccines ineffective in a year or less.

Potential side effects have been another concern. Rare occurrences of a blood-clotting syndrome have been linked to the Oxford-AstraZeneca and Johnson & Johnson vaccines, but experts say the benefits still outweigh the risks.

A fact overshadowing any good news about vaccines is that much of the world hasn’t yet been able to receive any doses at all. One analysis suggested that more than 85 countries, mostly in Africa, won’t have widespread COVID-19 vaccine access before 2023.

Below is a visualization of COVID-19 vaccination doses administered per 100 people between January and May of this year – each country turns white as data becomes available, then progressively darker blue as the number of administered doses increases.

US date format.
COVID-19 vaccination doses administered per 100 people between January and May of this year. Image: World Economic Forum

According to the Centers for Disease Control in the US, fully vaccinated people should be able to resume activities without masks (except where mandated), and travel without testing or quarantining. Still, experts caution against gatherings of multiple households without precautions if some people there are unvaccinated.

A study published in April in the UK found that receiving a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines notably reduced the odds of infecting other household members, and another published last month found that the viral load was significantly diminished for people in Israel infected a couple of weeks past their first dose of Pfizer-BioNTech – making them less infectious to others.

Yet another study published by the US CDC last month showed that two doses of the Pfizer-BioNTech and Moderna vaccines reduced the risk of healthcare workers getting sick with COVID-19 by 94%.

Researchers are still gathering what scant evidence has accumulated so far on how long protection lasts after vaccination. The role of booster shots may start to become clearer in September, when results from a study in England providing boosters to people at least 10 weeks past their second vaccine dose are anticipated.

Unfortunately, a significant number of people remain reluctant to be vaccinated. In the US, recent poll results showed that 24% of adults said they don’t plan to be vaccinated – and 78% of those people were unlikely to reconsider.

Another report published last month found that even though just 64% of adults in the US said they’d gotten at least one vaccine dose or intended to, general enthusiasm about getting vaccinated was reaching a plateau.

Image: World Economic Forum

For more context, here are links to further reading from the World Economic Forum’s Strategic Intelligence platform:

  • How about a “universal” coronavirus vaccine to prevent the next pandemic? This piece delves into an effort to develop next-generation immunization to protect against known and unknown varieties. (Scientific American)
  • One proven means to overcome vaccine hesitancy in a remote area of India has been to address concerns in Korku, an endangered language still spoken by at least 600,000 indigenous people. (IndiaSpend)
  • People with disabilities haven’t been prioritized for vaccination, according to this opinion piece, even though they account for a disproportionate number of adverse outcomes including a mortality rate in the UK roughly twice that of the general population. (Devex)
  • When a respected medical historian agreed to appear in a documentary about the pandemic, according to this report, she assumed it would be a straightforward piece of journalism – not anti-vaccination propaganda aimed at Black Americans. (Kaiser Health News)
  • Unvaccinated children seem to be reaping the benefits of mass COVID-19 vaccination programmes, but according to this analysis experts disagree on whether these children may now be a potential hotbed for the emergence of new variants. (Nature)
  • Vaccine myth buster: this paper focuses on myths fuelling vaccine hesitancy, and examines the most prevalent related topics including formaldehyde, aluminium, mercury, autism, and misconceptions regarding COVID-19 vaccines. (Frontiers)
  • The global vaccination effort has been nothing short of extraordinary, according to this analysis, but the overwhelming majority of the world’s population remains unprotected. (Project Syndicate)

On the Strategic Intelligence platform, you can find feeds of expert analysis related to Vaccination, COVID-19 and hundreds of additional topics. You’ll need to register to view.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

How global trade can save lives and livelihoods – and help protect the planet

From philanthropy to profit: how clean energy is kickstarting sustainable development in East Africa

Would you want to live to 150? Top quotes on what it means to grow old

Saudi Arabia: UN experts push for prompt release of women human rights defenders

EU ready to relinquish its internal tax havens

The megatrend that will shape our working future

Why people with disabilities are your company’s untapped resource

Time to say goodbye to the plastic straw. But what’s the best alternative?

Can Obama attract Iran close to the US sphere of influence?

How COVID-19 is helping Oman develop a future-ready workforce

Africa-Europe Alliance: EU boosts pan-African Internet connectivity with €30 million

This US city put an algorithm in charge of its school bus routes and saved $5 million

Why the financial scandals multiply?

Heading back to the cinema, theatre or a concert? Here are 3 ways the arts are adapting to COVID-19

Russia – US in Syria: Selling Afrin to Turkey but facing off ruthlessly for Ghouta

‘A trusted voice’ for social justice: Guterres celebrates 100 years of the International Labour Organization

Europe slammed by Turkey’s shaky Erdoğan; both playing with immigrants’ agony

America writes-off Iran, blocks Europe’s Tehran talks

Amazon indigenous groups want to create a nature sanctuary the size of Mexico

4 steps towards wiping out cervical cancer

Stepped-up efforts needed to combat pneumonia; save nearly nine million children’s lives

Built by a woman: supporting the dreams of mum entrepreneurs

Sustainable Development Goals: making the world a better place

European Accessibility Act: Parliament and Council negotiators strike a deal

Inclusion, empowerment and equality, must be ‘at the heart of our efforts’ to ensure sustainable development, says UN chief

Libya: €2 million in humanitarian assistance to cover basic needs

Ditching plastic straws isn’t enough. Here’s how to achieve zero waste.

Commission Work Programme 2019: Delivering on promises and preparing for the future

COVID-19: A coordinated EU health strategy needed, say MEPs

Turkey: Commission continues humanitarian support for refugees

Do we need a new Marshall Plan to rebuild Europe after COVID-19?

European Youth Forum demands immediate action & binding agreement on climate change

FROM THE FIELD: Conversations about Conservation

Monday’s Daily Brief: UN chief talks climate action at G7, WFP official visits camp in Central African Republic, Deadly violence at Lesvos migrant centre, Security Council meets on AU-UN Darfur mission

Alice in Colombia

Will the Greek economy ever come back to growth?

ECB’s €1.14 trillion again unifies Eurozone; Germany approves sovereign debt risks to be pooled

Alcoholic drinks: Commission tables update of rules governing alcohol excise duties

Vaccination campaigns are wars against fake news

“ASEM: Global Partners for Global Challenges”, a Sting Exclusive by China’s Ambassador to the EU

This is what’s happening to the Amazon, according to NASA

3 reasons why data is not the new oil – and why this matters to India

World’s Press Calls on the United Kingdom to Address Press Freedom Concerns

Britain in and out of the EU

State aid: Commission approves €2.9 billion public support by twelve Member States for a second pan-European research and innovation project along the entire battery value chain

Dangerous Trumpism in the Middle East with an anti-European edge

First seat projections for the next European Parliament

European Business Summit 15th year: Controversy and Constructive Ideas

3 cognitive biases perpetuating racism at work – and how to overcome them

President Michel’s MFF proposal not acceptable for Parliament

Why Sweden’s cashless society is no longer a utopia

Brexit: reciprocal visa-free access for EU and UK nationals

China-EU Trade and Economic Relations in Numbers

Britain declares trade war on mainland Europe

How governments can redesign support for entrepreneurs after COVID-19

Ozone on track to heal completely in our lifetime, UN environment agency declares on World Day.

5 milestones in green energy

Mergers: Commission prohibits proposed merger between Tata Steel and ThyssenKrupp

After swallowing effortlessly the right to be forgotten time for Google Ads now to behave

New Zealand can improve well-being through better policymaking and reforms to housing and migration policy

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s